URL of this page: https://medlineplus.gov/genetics/gene/aga/

AGA gene

aspartylglucosaminidase
From Genetics Home Reference. Learn more

Normal Function

The AGA gene provides instructions for producing an enzyme called aspartylglucosaminidase. This enzyme is active in lysosomes, which are structures inside cells that act as recycling centers. Within lysosomes, the enzyme helps break down complexes of sugar molecules (oligosaccharides) attached to certain proteins (glycoproteins). Specifically, this enzyme cuts glycoproteins between a protein building block (amino acid) called asparagine and a sugar molecule called N-acetylglucosamine. This cut is one of the last steps in breaking down a glycoprotein in the lysosome.

Health Conditions Related to Genetic Changes

Aspartylglucosaminuria

More than 30 mutations in the AGA gene have been found to cause aspartylglucosaminuria. Most of these mutations change one amino acid in aspartylglucosaminidase. One mutation found in 98 percent of people with this condition in Finland replaces the amino acid cysteine with the amino acid serine at position 163 in the enzyme (written as Cys163Ser or C163S). Many mutations, including C163S, disrupt the proper folding of aspartylglucosaminidase, resulting in an enzyme that cannot effectively break down glycoproteins. A buildup of glycoproteins seems to particularly affect nerve cells in the brain; loss of these cells causes a progressive decline in mental functioning and the other signs and symptoms of aspartylglucosaminuria.

More About This Health Condition

Other Names for This Gene

  • ASRG
  • glycosylasparaginase
  • N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase
  • N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase

Additional Information & Resources

Tests Listed in the Genetic Testing Registry

Scientific Articles on PubMed

Catalog of Genes and Diseases from OMIM

Research Resources

References

  • Aronson NN Jr. Aspartylglycosaminuria: biochemistry and molecular biology. Biochim Biophys Acta. 1999 Oct 8;1455(2-3):139-54. Review. Citation on PubMed
  • Saarela J, Laine M, Oinonen C, von Schantz C, Jalanko A, Rouvinen J, Peltonen L. Molecular pathogenesis of a disease: structural consequences of aspartylglucosaminuria mutations. Hum Mol Genet. 2001 Apr 15;10(9):983-95. Citation on PubMed
  • Saarela J, Oinonen C, Jalanko A, Rouvinen J, Peltonen L. Autoproteolytic activation of human aspartylglucosaminidase. Biochem J. 2004 Mar 1;378(Pt 2):363-71. Citation on PubMed or Free article on PubMed Central
From Genetics Home Reference

Genetics Home Reference has merged with MedlinePlus. Genetics Home Reference content now can be found in the "Genetics" section of MedlinePlus. Learn more

The resources on this site should not be used as a substitute for professional medical care or advice. Users with questions about a personal health condition should consult with a qualified healthcare professional.